文献速递结核与非结核分枝杆菌细菌感染、耐药与抗菌药物

俄罗斯耐贝达喹啉结核分枝杆菌分离株中atpE突变高发

High Prevalence of atpE Mutations in Bedaquiline-Resistant Mycobacterium tuberculosis Isolates, Russia.
PubMed 文献 · Emerg Infect Dis · 2025-01-01

分析9例接受贝达喹啉方案治疗且培养持续阳性患者的11株分离株,8株耐药株中4株检出AtpE取代(Ile66Met与Glu61Asp各2例),并发现mmpL5、mmpL4、atpB等基因突变可能影响贝达喹啉敏感性。

要点

  • 8株贝达喹啉耐药分离株中4株检出AtpE取代,Ile66Met与Glu61Asp各2例。
  • mmpL5(Asn772Thr)在贝达喹啉治疗期间出现,AtpB(Val165Leu)与mmpR5功能缺失突变同时见于1株敏感株。
  • mmpL4外排基因功能缺失突变以混合状态检出,另1例mmpL4突变伴贝达喹啉MIC成比例升高。

核心结论

  • 贝达喹啉耐药结核分枝杆菌临床分离株中AtpE取代发生率较高,mmpL5、mmpL4和atpB基因突变可能影响贝达喹啉敏感性。

研究设计与样本

  • 分析9例接受贝达喹啉为基础方案治疗且治疗开始后长时间培养阳性患者的11株分离株。

主要发现

  • 8株耐药分离株中4株检出AtpE取代,Ile66Met和Glu61Asp各2例。
  • MmpL5(Asn772Thr)在贝达喹啉治疗期间出现。
  • AtpB(Val165Leu)在1例中与mmpR5功能缺失突变同时见于1株敏感株。
  • mmpL4外排基因功能缺失突变以混合状态检出,提示耐药分离株中持续选择。
  • 回顾性基因组分析另发现1例mmpL4突变出现并伴贝达喹啉MIC成比例升高。

关键数值与推荐

  • 8株贝达喹啉耐药分离株中4株检出AtpE取代。
  • AtpE Ile66Met与Glu61Asp各2例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bedaquiline is a cornerstone drug for treating drug-resistant tuberculosis. We analyzed 11 isolates from 9 patients who were treated with a bedaquiline-based regimen and remained culture-positive long after treatment start. In 4 of 8 resistant isolates, we found substitutions in AtpE, which encodes subunit c of the Mycobacterium tuberculosis ATP synthase and is rarely identified in clinical isolates. We found Ile66Met and Glu61Asp substitutions in 2 cases each. Additional mutations in mmpL5, mmpL4, and atpB genes could affect the susceptibility to bedaquiline. MmpL5(Asn772Thr) emerged during bedaquiline treatment, whereas AtpB(Val165Leu) was found in 1 case simultaneously with the loss-of-function mmpR5 mutation in a susceptible strain. The loss-of-function mutation in the mmpL4 efflux gene was identified in the mixed state, pointing to ongoing selection in a bedaquiline-resistant isolate. Another case of the emergence of the mmpL4 mutation, accompanied by a proportional increase in bedaquiline MIC, was identified by retrospective analysis of genomes from bedaquiline-resistant isolates.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Zimenkov D, Ushtanit A, Gordeeva E, et al. High Prevalence of atpE Mutations in Bedaquiline-Resistant Mycobacterium tuberculosis Isolates, Russia. Emerg Infect Dis. 2025. PMID: 40023803. doi:10.3201/eid3103.241488

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。